Due to a fast time-to-answer, portability and panel of probes, the In-Check™ platform is particularly suited for diagnostic applications in which it is useful to simultaneously screen a number of sequences. Additional pathogens can be added to a panel without any additional cost.
Moreover, the simplification of operations needed, the self-contained nature of the chip and the reduced footprint of the instrumentation make it an ideal platform to develop Point-of-Care applications. |
 |
| |
 |
Clinical Diagnostics
| - |
Infectious Diseases (proved for bacteria, virus and parasites)
|
Respiratory panel |
|
Sepsis |
|
Urinary infectious & STD |
|
Antibiotic resistant panel |
|
Many others |
|
| - |
Oncology |
| - |
Genetic Testing
|
Pharmacogenomics/ Personalized Medicine |
|
Genetic Predisposition |
|
|
|
Industrial & Veterinary Diagnostics
| - |
Food and Water Safety |
| - |
Animal Health & Safety |
| - |
Environmental Monitoring |
| - |
Bioterrorism |
|
|
Research
| - |
Pharma/Biotech |
| - |
Academic |
|
|
| |
| Partners - Application Example |
 |
| |
|
Designed for the rapid simultaneous identification of sepsis-causing bacteria |
|
Comprehensive pathogen panel covers over 90% of all sepsis cases |
|
First version will work from bacterial cultures, later versions directly from blood samples |
|
Has already been validated with > 100 patient samples. |
|
| |
|
|
|
